EFFECT OF ANGIOTENSIN-II RECEPTOR ANTAGONIST LOSARTAN AND ITS COMBINATION WITH DIURETICS ON MYOCARDIAL MORPHO-FUNCTIONAL CONDITIONS IN HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY

EFFECT OF ANGIOTENSIN-II RECEPTOR ANTAGONIST LOSARTAN AND ITS COMBINATION WITH DIURETICS ON MYOCARDIAL MORPHO-FUNCTIONAL CONDITIONS IN HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY

Aim. To compare the effects of long-term therapy with angiotensin-II receptor antagonist losartan, alone or in combination with hydrochlorothiazide, and amlodipine treatment on left ventricular morpho-functional variables and blood pressure (BP) in hypertensive patients.Material and methods. 25 wome...

Full description

Bibliographic Details
Main Authors:	S. N. Tolpygina, E. V. Oschepkova, L. M. Sergakova, A. N. Rogoza
Format:	Article
Language:	English
Published:	Столичная издательская компания 2016-01-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	arterial hypertension left ventricular hypertrophy comparative study angiotensin-ii receptor antagonists calcium channel blockers losartan amlodipine
Online Access:	https://www.rpcardio.online/jour/article/view/1067

Similar Items

Reduction in left ventricular hypertrophy in hypertensive patients treated with enalapril, losartan or the combination of enalapril and losartan
by: Antônio Carlos Avanza Jr, et al.
Published: (2000-02-01)

Left ventricular hypertrophy: renin4angiotensin system role
by: F. T. Ageev, et al.
Published: (2008-04-01)

Left ventricular hypertrophy: prognostic value, pathogenesis, possible remodeling: focusing on angiotensin receptor antagonists
by: M. D. Smirnova, et al.
Published: (2007-12-01)

Efficacy of fixed-dose amlodipine and losartan combination compared with amlodipine monotherapy in stage 2 hypertension: a randomized, double blind, multicenter study
by: Lee Hae-Young, et al.
Published: (2011-10-01)

Amlodipine-induced reversible gum hypertrophy
by: Gutch Manish, et al.
Published: (2016-01-01)

A multi-center phase II randomized clinical trial of losartan on symptomatic outpatients with COVID-19
by: Michael A. Puskarich, et al.
Published: (2021-07-01)

Missing diagnosis: Gingival hypertrophy due to amlodipine
by: L.R. Tomar, et al.
Published: (2015-09-01)

Losartan for Preventing Aortic Root Dilatation in Patients with Marfan Syndrome: A Meta-Analysis of Randomized Trials
by: Ayman Elbadawi, et al.
Published: (2019-10-01)

Angiotensin 1-7 and losartan worsen the cisplatin induced nephrotoxicity in female rats
by: Sayyedehnikta Kasaei, et al.
Published: (2022-01-01)

Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome
by: Fini Massimo, et al.
Published: (2005-05-01)

A fixed combination of amlodipine and losartan: effectiveness and safety in abnormal weather conditions in patients with arterial hypertension
by: F T Ageev, et al.
Published: (2016-12-01)

Cutaneous ulcers in association with sprue‐like enteropathy secondary to Losartan
by: Francis Essien, et al.
Published: (2021-08-01)

The effect of losartan on angiotensin II-induced cell proliferation in a rat aorta smooth muscle cell line
by: Natália Tambelline, et al.
Published: (2012-04-01)

СARDIOPROTECTION IN PATIENTS WITH HYPERTENSION – THE ROLE OF LOSARTAN
by: I. I. Chukaeva, et al.
Published: (2015-09-01)

Effects of physical exercise combined with captopril or losartan on left ventricular hypertrophy of hypertensive rats
by: Quênia Janaína Tomaz de Castro, et al.
Published: (2021-08-01)

Losartan and diabetic nephropathy: commentaries on the RENAAL study
by: Tenenbaum Alexander, et al.
Published: (2002-04-01)

From the choice of antihypertensive drug to the choice of fixed combinations of antihypertensive drugs: a paradigm shift
by: O D Ostroumova, et al.
Published: (2015-12-01)

Effects of renin-angiotensin system blockers on left ventricular hypertrophy and biochemical markers of collagen balance in patients with hypertensive hypertrophy
by: A G Ovchinnikov, et al.
Published: (2009-05-01)

Effect of angiotensin II receptor blockers and calcium antagonists on cognition
by: O. D. Ostroumova, et al.
Published: (2016-12-01)

A fixed combination of amlodipine and losartan: effectiveness and safety in abnormal weather conditions in patients with arterial hypertension
by: Ageev F.T., et al.
Published: (2016-12-01)

Efficacy and safety of losartan in childhood immunoglobulin A nephropathy: a prospective multicenter study
by: Hyesun Hyun, et al.
Published: (2023-12-01)

Resveratrol Suppresses Cardiac Renin Angiotensin System in the Late Phase of Left Ventricular Hypertrophy
by: Tahmineh Hashemizadeh, et al.
Published: (2019-04-01)

Losartan Alleviates the Side Effects and Maintains the Anticancer Activity of Axitinib
by: Ying Fu, et al.
Published: (2022-04-01)

Association Between the Angiotensin II/Angiotensin (1-7) Imbalance and Left Ventricular Hypertrophy in Patients with Heart Failure
by: Nikolov A., et al.
Published: (2021-10-01)

The role of angiotensin receptor antagonists in treatment of arterial hypertension: focus on losartan
by: Galina Anatol'evna Baryshnikova, et al.
Published: (2009-03-01)

Efficacy and safety of single-pill amlodipine/losartan versus losartan in patients with inadequately controlled hypertension after losartan treatment: a multicenter, double-blind, randomized phase III clinical trial
by: Shuyang Zhang, et al.
Published: (2023-06-01)

The effect of angiotensin 1-7 and losartan on renal ischemic/reperfusion injury in male rats
by: Tahereh Safari, et al.
Published: (2019-01-01)

Combining losartan with radiotherapy increases tumor control and inhibits lung metastases from a HER2/neu-positive orthotopic breast cancer model
by: Wende Li, et al.
Published: (2021-03-01)

Perspectives of using angiotensin receptor antagonists
by: V V Fomin
Published: (2009-06-01)

Cardiorenal Systems Modeling: Left Ventricular Hypertrophy and Differential Effects of Antihypertensive Therapies on Hypertrophy Regression
by: K. Melissa Hallow, et al.
Published: (2021-06-01)

Clinical effectiveness and safety of amlodipine/losartan‐based single‐pill combination therapy in patients with hypertension: Findings from real‐world, multicenter observational databases
by: Jieun Lee, et al.
Published: (2021-11-01)

Local Application of Leptin Antagonist Attenuates Angiotensin II–Induced Ascending Aortic Aneurysm and Cardiac Remodeling
by: Danny Ben‐Zvi, et al.
Published: (2016-05-01)

ECONOMIC EVALUATION OF COMBINED THERAPY OF ARTERIAL HYPERTENSION BY MARKOV’S MODELING
by: N. S. Maksimchuk-Kolobova, et al.
Published: (2015-09-01)

ECONOMIC EVALUATION OF COMBINED THERAPY OF ARTERIAL HYPERTENSION BY MARKOV’S MODELING
by: N. S. Maksimchuk-Kolobova, et al.
Published: (2015-09-01)

A randomised clinical trial study assessing the efficacy of 5% losartan potassium loaded in ethosomal gel to treat human keloids: a trial protocol
by: Yuni Eka Anggraini, et al.
Published: (2024-01-01)

Left ventricular hypertrophy and renin-angiotensin-aldosterone system: AT1-receptor blockers are in the focus
by: A V Barsukov, et al.
Published: (2013-03-01)

The role of angiotensin receptor blocker (losartan) on decreasing fibrotic process of corpora cavernosa in priapism model of wistar rats [version 3; peer review: 1 approved, 2 approved with reservations]
by: Rangga Adhazi Ksatriapraja, et al.
Published: (2024-02-01)

The role of angiotensin receptor blocker (losartan) on decreasing fibrotic process of corpora cavernosa in priapism model of wistar rats [version 2; peer review: 1 approved, 2 approved with reservations]
by: Rangga Adhazi Ksatriapraja, et al.
Published: (2023-05-01)

Effect of selective angiotensin antagonists on the antidiuresis produced by angiotensin-(1-7) in water-loaded rats
by: Baracho N.C.V., et al.
Published: (1998-01-01)

Renin angiotensin system and cardiac hypertrophy after sinoaortic denervation in rats
by: Aline Cristina Piratello, et al.
Published: (2010-01-01)